The page is the record's research on the issuer — no analyst, no rating, no view. # Bicara Therapeutics Inc. (NASDAQ: BCAX) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Bicara Therapeutics Inc., listed on NASDAQ under the ticker BCAX, with ISIN US0554771032 and LEI not on the record (no GLEIF record with the exact legal name in jurisdiction US-DE). Its security type is Corporate, its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Delaware. The issuer is listed and not halted. ## The disclosure read The record holds 146 filings in the twelve months to 2026-11-08, across 81 filing days, with a median gap of 2.0 days between filing days. The median gap for NASDAQ is 6.0 days across 4359 issuers, and the median gap for 2834 Pharmaceutical Preparations is 6.0 days across 526 issuers. Days from the latest filing to the record date are 18, against a NASDAQ median latency of 5.0 days and a sector median latency of 4.0 days. The latest filing is dated 2026-10-21 and is of type regulatory_filing. By type, the window holds 57 directors_dealings, 68 regulatory_filing, 8 results, 6 corporate_news, 3 agm_egm, 3 prospectus and 1 director_change. ## Auditor The auditor of record is KPMG LLP, located in Boston, Massachusetts. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag reads listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client_categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's own investor-relations page. The count is 0. ## Open research No openly published research notes were found. The count of notes on the record is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The sealed years that hold the issuer are 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0002023658.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/BCAX (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/2023658/000162828026022010/bcax-20251231.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/BCAX (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/BCAX · public-record only · the same page signed and receipted: get_research at https://mcp.getissuer.ai/mcp